Member Info for calisto

on POLX. Looks like good tech, nobody at risk of dying just much improved diagnosis so no "angst" from the "overzealous" FDA and $500m/yr sales. Lots of peeps with lung disease like Asthma, COPD and so on. P3 now

Oh sorry the have just found a whingeing florist

are working over the Port of Dover at the moment canvassing "opinion" from lorry drivers waiting to cross the Channel. They are having to keep moving because many are saying they are already being checked and "its not gonna make a difference mate" "if we have no deal". lol not what the Ed wants to go out over the airwaves eh Remoaners. ?

I wonder how they let Ibruprofen and related drugs through given the damage they do to the intestinal tract.

The three "amigos" are lucky they are not in medieval times. carrying from Becket/henry 2 lol

yep women! lol. At least it was better than Ed 2 I suppose.

and died of a perforated ulcer with his legitimate sons fighting him.

did not do him much good in the end.

they have a choice

The EU will not want to pay tariffs to import into the UK. Individual member states will break rank.

Thats great to know! Meanwhile patients continue to die unnecessarily.

huh? managers and monkeys same thing these days.

little bit of something vs something of nothing?

They are all facing deselection anyway for not reflecting the will of the constancy that elected them. There are a couple more I believe Letwin is also facing the chop.

Lloy out perform handsomely today. Sterling strength is holding back the market i guess as markets are watching unfolding developments in the Labour Party as MP's are beginning to realise that they did not sign up to become members of undemocratic neo Marxist organisation. A diminishing prospect of a Corbyn led Government is of course excellent news for the country's economy, banks etc, and consequentially Sterling. Once a couple of sheep have gone through the gap in the fence more normally follow. Here's hoping for more to come and we will see the true ugly face of Corbyn's Labour as they try to stem the flow

When the SP is near tangible book value buy backs can be quite efficient from a balance sheet perspective. It is well understood that buy backs and " specials" are used to distribute surplus capital. Give the dilution shareholders have faced historically the rate the shares are being bought back is little more than a dribble in a bucket. There are more aggressive things that can be done but I guess until PPI is over and the Brexit dust has settled this is the best we can expect for now with perhaps little more at the half year stage. The problem with higher dividends is the difficulty of rowing it back if macro conditions change for the worse. With the EU fitting with recession and global growth sputtering we should be relatively satisfied what we have got today. It does give a glimpse of what we may be able look forward to over the next couple of year ahead. Once the elephants that are sitting on our chest get up we will truly be able to stretch our legs.

The underlying ratios all look pretty solid showing the business is still on an improving health trajectory despite the headwinds we have seen and are still expected to see over the next couple of years esp given the UK centric nature of the banks as it is now and the continues fretting over the type of Brexit we will experience. There is little doubt the "angst " over Brexit has held our SP back so once the fog clears this bank will likely be a sector champion. The decision to come will be focused on growth international acquisitions as market share limitation prevents us from increasing our domestic market share. Theres is a lot to like in these superficially dull numbers.

His pain? Stockholm Syndrome! Investors have lost life changing sums of money here. That's real pain. GL and his BoD get paid anyway. They should have had ALL bases covered that's why we pay them what we do. I am sure it won't be an issue but even so the buck stops with company. This is what they are supposed to do. They even delayed the filing to make sure they had all their ducks in row. They overlooked the bloody great big goose waddling at the end of the line. They were lucky that nobody asked them that question this afternoon. We have to decide whether or not this drug is a good one. I am worried about Skin infections as I know someone who almost died in their early twenties and I know others who have the stay in hospital for another three weeks to fight off MRSA. We are running out of viable AB's. These guys managed to lay their hands on what looks to be a promising new AB which is the reason I am still in. I hope we get the FDA on board and soon but sulking CEO is just plain pathetic. A bit of humility would have been appropriate.

Why when you were closely with the FDA was the "liver issue" not raised earlier in the rolling submission process and the necessary back up date made available for review.

seems a bit rich that the FDA decides who lives and who dies in the rest of the world.